NSCLC: palliative care referral uncommon for advanced disease

  • Clin Lung Cancer

  • curated by Kelli Whitlock Burton
  • Univadis Clinical Summaries
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Fewer than 20% of oncologists from a nationwide directory prescribed early palliative care (PC) for their advanced NSCLC patients.
  • The study also surveyed advanced NSCLC patients treated at a single center, 94% of whom received no PC referral.

Why this matters

  • Based on a landmark study that found early PC improved QoL and prolonged survival, early integration of PC for advanced NSCLC patients was added to treatment guidelines.

Study design

  • Survey of 93 oncologists from the 2015 IASLC membership directory and 100 patients with advanced NSCLC.
  • Funding: None.

Key results

  • 83% of oncologists said evidence supports early PC, but 40% said their clinical experience only supported a QoL benefit.
  • 58% said most or all metastatic patients should be referred for early PC, but only about 19% make referrals at time of diagnosis.
  • 94% of patients reported no PC referral and 64% had never heard of PC.
  • Among oncologists who referred

Limitations

  • Most oncologists were at large academic centers.